NR1H4 and metabolic dysfunction-associated steatohepatitis: Elevated fecal DCA levels in MASH patients, together with a reduced abundance of Bacteroides, promote activation of hepatic farnesoid X receptor (FXR) and Takeda G protein–coupled receptor 5 (TGR5), enhancing pro-inflammatory and pro-fibrotic signaling [39].